apomorphine has been researched along with Muscle Rigidity in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (47.37) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Kadiri, SK; Karkar, VV; Pal Roy, S; Rao Konijeti, S | 1 |
| Chen, X; Jia, L; Liu, H; Shi, L; Xie, J | 1 |
| Brosnan, RJ; Mayhew, PD; Smith, A; Soares, JH | 1 |
| Alberts, JL; Ghosh, D; Johnson, MD; Mera, TO; Rothe, D; Vitek, J; Xu, W; Zhang, J | 1 |
| Matsumura, M | 1 |
| Bartolić, A; Pirtosek, Z; Ribaric, S; Rozman, J | 1 |
| Johnels, B | 1 |
| Fujita, H; Shirasaki, K; Watanabe, H; Watanabe, K | 1 |
| Johnels, B; Steg, G | 1 |
| Chollet, F; Marc-Vergnes, JP; Montastruc, JL; Rascol, A; Rascol, OJ; Sabatini, U | 1 |
| Poewe, W; Schelosky, L; Scholz, U; Schrag, A | 1 |
| Fiaschi, A; Idone, D; Tezzon, F; Tinazzi, M; Zanette, G | 1 |
| Johnels, B; Steg, G; Ungerstedt, U | 1 |
| Andén, NE; Johnels, B | 1 |
| Barnett, A; Goldstein, JM; Malick, JB | 1 |
| Cox, M; Markus, HS; Tomkins, AM | 1 |
| Maxwell, DR; Read, MA; Sumpter, EA | 1 |
| Ngai, SH | 1 |
| Kuschinsky, K; Sontag, KH; Wand, P | 1 |
2 review(s) available for apomorphine and Muscle Rigidity
| Article | Year |
|---|---|
Experimental parkinsonism in primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Apomorphine; Basal Ganglia; Bicuculline; Cerebral Cortex; Disease Models, Animal; Dopamine; Dopamine Agonists; Electrocoagulation; GABA Antagonists; Globus Pallidus; Humans; Models, Neurological; MPTP Poisoning; Muscle Rigidity; Neurotoxins; Parkinsonian Disorders; Primates; Substance-Related Disorders; Substantia Nigra; Tegmentum Mesencephali; Thalamus | 2001 |
Parkinsonism, levodopa, and anesthesia.
Topics: Amantadine; Anesthesia; Animals; Apomorphine; Benperidol; Blood-Brain Barrier; Brain; Cardiovascular Diseases; Catecholamines; Dihydroxyphenylalanine; Dopamine; Fentanyl; Humans; Mice; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Pulmonary Edema; Rats | 1972 |
1 trial(s) available for apomorphine and Muscle Rigidity
| Article | Year |
|---|---|
Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Apomorphine; Biperiden; Cholinergic Antagonists; Cross-Over Studies; Dopamine Agonists; Female; Humans; Hypokinesia; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Single-Blind Method; Tremor | 1999 |
16 other study(ies) available for apomorphine and Muscle Rigidity
| Article | Year |
|---|---|
Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adjuvants, Immunologic; Animals; Antioxidants; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Brain; Catalepsy; Catatonia; Dopamine; Haloperidol; Hypokinesia; Muscle Rigidity; Plant Bark; Rats; Reserpine; Tabebuia; Tremor; Water | 2022 |
The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
Topics: Animals; Anthracenes; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Dopaminergic Neurons; Infusions, Intraventricular; KCNQ Potassium Channels; Male; Motor Activity; Muscle Rigidity; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Potassium Channel Blockers; Rats, Wistar; Substantia Nigra | 2018 |
Rabbit model of chest wall rigidity induced by fentanyl and the effects of apomorphine.
Topics: Analgesics, Opioid; Animals; Apomorphine; Disease Models, Animal; Dopamine Agonists; Fentanyl; Lung Compliance; Muscle Rigidity; Rabbits; Thoracic Wall | 2014 |
Objective quantification of arm rigidity in MPTP-treated primates.
Topics: Animals; Antiparkinson Agents; Apomorphine; Arm; Deep Brain Stimulation; Disease Models, Animal; Electromyography; Electronic Data Processing; Female; Macaca mulatta; MPTP Poisoning; Muscle Rigidity; Muscle, Skeletal; Range of Motion, Articular | 2009 |
Postural stability of Parkinson's disease patients is improved by decreasing rigidity.
Topics: Antiparkinson Agents; Apomorphine; Humans; Middle Aged; Muscle Rigidity; Parkinson Disease; Posture | 2005 |
Reserpine-induced rigidity in rats: drug effects on muscle tone from corpus striatum and nucleus accumbens.
Topics: 5-Hydroxytryptophan; Animals; Apomorphine; Carbidopa; Corpus Striatum; Male; Muscle Rigidity; Nucleus Accumbens; Rats; Rats, Inbred Strains; Reserpine; Septal Nuclei; Trifluoperazine | 1983 |
[Electromyographic quantification of muscle rigidity in rats caused by morphine and drug actions on the symptoms].
Topics: Animals; Apomorphine; Electromyography; Male; Mephenesin; Morphine; Muscle Rigidity; Rats; Rats, Inbred Strains | 1983 |
A mechanographic method for measurement of muscle tone in the conscious rat. The calf muscle stretch response in reserpine-induced rigidity.
Topics: Animals; Apomorphine; Biomechanical Phenomena; Disease Models, Animal; Haloperidol; Male; Muscle Contraction; Muscle Rigidity; Muscle Tonus; Neurophysiology; Parkinson Disease, Secondary; Rats; Rats, Inbred Strains; Reflex, Stretch; Reserpine | 1982 |
Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
Topics: Aged; Apomorphine; Brain; Dopamine; Female; Humans; Injections, Subcutaneous; Levodopa; Male; Middle Aged; Motor Activity; Motor Cortex; Movement Disorders; Muscle Rigidity; Neurologic Examination; Parkinson Disease; Regional Blood Flow; Somatosensory Cortex; Tomography, Emission-Computed, Single-Photon | 1993 |
Parkinson's disease and lower limb somatosensory evoked potentials: apomorphine-induced relief of the akinetic-rigid syndrome and vertex P37-N50 potentials.
Topics: Aged; Antiparkinson Agents; Apomorphine; Brain Stem; Electrophysiology; Evoked Potentials, Somatosensory; Female; Humans; Leg; Male; Middle Aged; Movement Disorders; Muscle Rigidity; Parkinson Disease; Syndrome | 1999 |
A method for mechanographical recording of muscle tone in the rat: the effect of some antiparkinsonian drugs on rigidity induced by reserpine.
Topics: Animals; Antiparkinson Agents; Apomorphine; Bromocriptine; Carbidopa; Drug Evaluation, Preclinical; Haloperidol; Levodopa; Male; Muscle Rigidity; Muscle Tonus; Myography; Rats; Reserpine | 1978 |
Effect of local application of apomorphine to the corpus striatum and to the nucleus accumbens on the reserpine-induced rigidity in rats.
Topics: Animals; Apomorphine; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Male; Muscle Rigidity; Nucleus Accumbens; Rats; Reserpine; Septal Nuclei | 1977 |
The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Carbidopa; Hindlimb; Levodopa; Male; Methamphetamine; Muscle Rigidity; Rats; Reserpine; Scopolamine; Time Factors; Trihexyphenidyl | 1975 |
Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity.
Topics: Apomorphine; Calorimetry, Indirect; Energy Metabolism; Female; Humans; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Rest | 1992 |
Pharmacology of M & B 18,706, a drug which selectively reduces decerebrate rigidity.
Topics: Adrenergic alpha-Antagonists; Animals; Apomorphine; Cats; Cerebellar Ataxia; Cerebellum; Chlorpromazine; Decerebrate State; Dextroamphetamine; Diazepam; Dimethylamines; Dogs; Electromyography; Ischemia; Locomotion; Muscle Relaxants, Central; Muscle Rigidity; Phenothiazines; Rats; Reflex; Spinal Cord; Tranquilizing Agents; Valerates | 1974 |
Morphine-induced muscular rigidity in rats.
Topics: Animals; Apomorphine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Electromyography; Male; Morphine; Muscle Rigidity; Naloxone; Narcotic Antagonists; Rats; Time Factors | 1973 |